Aims-This study aimed to characterise the status of viral infection in patients with HTLV-1 uveitis (HU) (0-54% (1P11%)). Most of the TSP/HAM patients also had a relatively high percentage (11-63% (7.67%)). The differences among these three groups were highly significant bythe Mann-Whitney U test. Conclusion-The results suggested that the increase in the number of HTLV-1 infected cells is one base for the development of inflammatory HU lesions, as it is for TSP/HAM. (Br_J Ophthalmol 1995; 79: 270-276) 
Aims-This study aimed to characterise the status of viral infection in patients with HTLV-1 uveitis (HU) by quantifying the circulating HTLV-1 infected ceils in the peripheral blood. Methods-Genomic DNA samples of peripheral blood mononuclear cells (PBMC) were obtained from 25 patients with HU, 14 patients with tropical spastic paraparesis/HTLV-1 associated myelopathy (TSP/HAM), and 21 asymptomatic carriers of HTLV-1. Quantitative polymerase chain reaction (PCR) of the gag region of HTLV-1 provirus DNA was performed on these DNA samples. To confirm the PCR, genomic Southern blot hybridisation was performed to identify integrated HTLV-1 provirus. This procedure detected a few percent of HTLV-1 infected celils in the PBMC. Results-Most of the HU patients had a significantly increased number of circulating HTLV-1 infected cells (mean (SD) 3 -84% (4.45%) of the PBMC), whereas the percentage of infected cells in most asymptomatic carriers was less than 1% (0-54% (1P11%)). Most of the TSP/HAM patients also had a relatively high percentage (11-63% (7.67%)). The differences among these three groups were highly significant bythe Mann-Whitney U test. Conclusion-The results suggested that the increase in the number of HTLV-1 infected cells is one base for the development of inflammatory HU lesions, as it is for TSP/HAM. (Br_J Ophthalmol 1995; 79: [270] [271] [272] [273] [274] [275] [276] The human T cell leukaemia virus type I (HTLV-1) is causatively associated with a T cell malignancy, adult T cell leukaemia (ATL), 1-7 and a chronic neurological disorder, tropical spastic paraparesis/HTLV-1 associated myelopathy (TSP/HAM). [8] [9] [10] [11] [12] Recently, we reported a new disease entity associated with HTLV-1, HTLV-1 uveitis (HU), based on our seroepidemiological, ophthalmic, and virological studies.13-8 HU was tentatively defined as an idiopathic uveitis of otherwise asymptomatic HTLV-1 carriers. Clinically, HU is characterised by a sudden onset of mild iritis, moderate or severe vitreous opacities, and mild retinal vasculitis in one or both eyes.18 Cytological examination of the cells in the anterior chambers from affected eyes disclosed that the infiltrating cells are predominantly lymphocytes with CD3 surface marker (Ono et al, submitted for publication). HTLV-1 infected cells were demonstrated in all the samples examined '3 by polymerase chain reaction (PCR). 19 The intraocular inflammation responded well to topical and/or systemic corticosteroids and the visual prognosis of HU is good in most patients. [16] [17] [18] TSP/HAM is a chronic inflammatory neurological disease of the CNS, mainly affecting the thoracic spinal cord resulting in spastic paraparesis. 20 21 Because of high levels of serum antibodies against HTLV-1 antigens and the presence of cytotoxic T cells in peripheral blood mononuclear cells (PBMC), the host immune response has been implicated as one of the pathogenetic mechanisms.22-29 One of the characteristic findings is that the number of HTLV-1 infected cells in the PBMC of patients is increased polyclonally or, in some cases, oligoclonally. [30] [31] [32] [33] [34] [35] Although the mechanism of this increase is not yet understood, it is speculated that the increased number of HTLV-1 infected cells is also relevant to the development of the inflammatory CNS lesions characterised by the infiltration of T lymphocytes. 20 21 We tested whether patients with HU, another inflammatory disease caused by HTLV-1, have an increased number of circulating HTLV-1 infected cells. We determined the number of HTLV-1 infected cells in fresh PBMC from these patients using semiquantitative PCR and conventional genomic Southern hybridisation. Our results indicated that the number of HTLV-1 infected cells in PBMCs is significantly increased in most HU patients compared with that of asymptomatic carriers, suggesting a common underlying HTLV-1 infection in HU and TSP/HAM patients. For semiquantitative PCR, template DNA samples for the patients and the control dilution series were amplified simultaneously, and one fifth of these products were resolved by 5% polyacrylamide gel electrophoresis followed by electrotransfer to a charged nylon membrane (Biodine B, Pall BioSupport Company, Glen Cove, NY, USA) using a semi-dry blotter. Thereafter, the membrane was denatured with 0-4 N NaOH and neutralised with 0'5 M TRIS HCl, pH 8-0, and fixed by ultraviolet irradiation. Hybridisation with a 32p labelled internal oligomer probe (G3) was done at 55°C in a hybridisation solution containing 4XSSC, 1 0XDenhardt solution, and 100 ,ug/ml of heat denatured E coli DNA. After washing in 2xSSC and 0 1% SDS at 550C, the hybridised signal was quantified using a Bio-Image Analyser BA100 (Fuji Film, Tokyo, Japan). To estimate the copy number of the HTLV-1 provirus in the template DNA, a standard curve on a semilog scale was constructed from the measured radioactivity in the control dilution series. The samples were assayed by 30 To test the sensitivity of the blot, a twofold dilution series of the positive control DNA was prepared using ATL DNA and DNA of the HTLV-1 negative human T cell line, Jurkat.
Ten jig of genomic DNA of this dilution series and the DNA samples were digested with PstI, which has six recognition sites within the HTLV-1 provirus genome. Following electrophoresis on a 1% agarose gel, the DNA was transferred to a nylon membrane by capillary blotting with 0-4 N NaOH. The membrane was neutralised with 0 5 M TRIS HCI, pH 8 0, fixed by ultraviolet irradiation and hybridised at 650C in a hybridisation solution containing 5-3 to 5'-dilution by 30 cycles (Fig 1) . Therefore, 30 cycles were considered optional for quantifying the products from most of the HU patients and asymptomatic carriers, whereas 25 cycles was used to quantify those in some of the TSP/HAM patients whose PBMC contained more than 10% of infected cells. Because the efficiency of amplification varied to some extent in each PCR, the control dilution series DNA and the patient samples were amplified simultaneously and analysed on the same gel and membrane. Some of these results are shown in Figure 2 , and they demonstrate the increased viral DNA load in HU patients (Fig 2, lanes 6 -10) compared with that of asymptomatic carriers (Fig 2, lanes 11-13) .
The calculated percentage of HTLV-1 infected cells in the PBMC in the three groups of HTLV-1 carriers was plotted on a semilog scale (Fig 3) . Among the 25 HU patients studied, 18 (72-0%) had more than 1% of infected cells. The percentage of HTLV-1 infected cells in the PBMC in HU patients ranged from 0d1% to 17%, with the mean (SD) of 3.84% (4.45%). Among the asymptomatic carriers, 17 of 21 (81.0%) contained less than 1% of HTLV-1 infected cells in the PBMC, with 11 out of 21 (52.4%) having about 0'1% or less (mean (SD) 0 54% (I11-%)). It is notable that four of the 21 samples (19%) contained over 1% of infected cells, which contributed to the wide distribution and relatively high mean percentage. The percentage of infected cells in one asymptomatic family member of a TSP/HAM patient was 0-25%. Of the 14 TSP/HAM patients, more than 5% of the infected PBMC were in 12 (85 7%) of them, the highest being 25% (mean (SD) 11 63% (7-67%)). The PBMC of the remaining two patients (14.3%) contained about 1% or less of Although the range was widely distributed in each group, the increases of the HTLV-1 infected cells in the PBMC of the patients with HU and TSP/HAM were both highly significant when compared with asymptomatic carriers (p=0*0001 for both by Mann-Whitney U test). The difference in the ratio of the infected cells between the patients with HU and TSP/HAM was also significant (p=0-0008 by Mann-Whitney U test).
hybridised bands of the internal restriction fragments were visible on the lanes of these control samples until 2-5 dilution, indicating that the assay can detect a low percentage of the infected cells among the HTLV-1 negative cells (Fig 4B, lanes 1-7) . On the same film, those hybridised bands were visible in three samples (Fig 4B, lanes 9, 10, 12) . The intensity of these bands were comparable with those of a 2-5 dilution of ATL DNA, indicating that these patients have about 3% or more HTLV-1 infected PBMC. No junction fragments containing the LTR sequence and flanking cellular DNA were detected in HU patients, suggesting that no clonal proliferation had occurred.
Although the sensitivity of our Southern blot analysis was close to the limit of the method itself, we further tried to increase the sensitivity of our assay by using a region specific probe. Figure 4C shows one of the results with an env region specific probe that detects a 2-4 kbp internal PstI fragment of the integrated HTLV-1 provirus DNA.
As for the samples in Figure 4B , semiquantitative PCR showed that about 1-6, 3-7, and 6-2% of the PBMC were infected in the HU patients in lanes 9, 10, and 12, respectively. The samples in lanes 8, 11, and 13 were also from HU patients. PCR had shown that they contained 0-066, 058, and 0-29% infected cells, respectively. The sample in lane 14 was from a seropositive patient with a different ocular disease whose PBMC contained 0 016% infected cells. In Figure 4C , a band of env region was detectable to 2-6 dilution, which corresponds to 1 56% of infected population. Based on the semiquantitative PCR results, the PBMC of HU patients in lanes 4 to 8 contained 3 7, 4-6, 6-2, 14-0, and 4X1% infected cells, respectively. Thus, these methods of semiquantifying the infected cells, PCR and Southern blot analysis, were comparable. However, Southern blots cannot be applied to samples that are infected at a low percentage.
GENOMIC SOUTHERN HYBRIDISATION
To confirm the increase of HTLV-1 infected cells by a different method, we studied the above samples by genomic Southern hybridisation of the integrated HTLV-1 provirus. PstI cleaves the HTLV-1 provirus at six sites, producing three large fragments from the internal region and two from the viral cellular junctions (Fig 4A) , if the provirus is intact. The representative HTLV-1 probe in this study covers the whole viral genome from the 5'-LTR to the 3'-LTR, so that all the fragments produced by PstI digestion, internal ones tive family members showed oligoclonal or monoclonal expansion of the HTLV-1 infected cells, whereas no clonal proliferation was detected in asymptomatic carriers in the general population. Our Southern blots of HU patients with representative and region specific probes also detected internal fragments of PstI digested HTLV-1 proviral DNA, indicating that more than a few percent of PBMC are infected with HTLV-1. About one third of the HU samples were positive in this assay, which roughly corresponds with the number that were shown by PCR to contain more than 3% infected cells. However, junction fragments containing LTR sequence have not yet been detected (Fig 4B) One of the non-structural, regulatory proteins of HTLV-1, Taxl, transactivates the expression of both viral and host cellular genes. Among the genes that are transactivated are those of cytokines such as IL-2, IL-3, IL-4, GM-CSF, and TGFP.47-5l Thus, it is conceivable that the increased number of HTLV-1 infected T cells may lead to disturbances in the host immune response through the presentation of viral antigens and/or aberrant functions induced by Taxl, which results in inflammatory disorders such as HU and TSP/HAM. Whether such pathogenetic processes are involved in these two disorders can be tested by characterising the immunological abnormalities and the status of the viral infection in HU patients and their family members.
In conclusion, we demonstrated that patients with HU and TSP/HAM have much more HTLV-1 infected T cells compared with asymptomatic carriers. These common features of viral infection might be the basis for the development of inflammatory disorders in HTLV-1 carriers.
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